uniQure (QURE) reported additional data from its ongoing Phase I/II studies of ifezuntirgene inilparvovec (AMT-130) for the treatment of Huntington's disease..

Turkey's economic confidence strengthened further in September to the highest level in more than three years. The economic sentiment index rose to 101.3 in September from 100.

CDT Equity (CDT) said Sarborg filed new IP applying quantum sampling to disease biology and drug discovery. Its model analyzed 150 disease networks, including Crohn's disease, COPD and psoriasis, identifying potential drug targets.

Medicus Pharma (MDCX) filed a registration-intent Phase 2b/3 protocol with the FDA for Teverelix, a long-acting GnRH antagonist for advanced prostate cancer patients at cardiovascular risk.

Gold prices rebounded on Tuesday as markets reacted to the dip in crude oil prices and the easing in bond yields. Pressured by the surge in crude oil prices and the spike in bond yields, the yellow metal had plunged more than 3.

U.S. liquefied natural gas producer Cheniere Energy, Inc. (LNG), announced on Tuesday that its marketing unit has signed a 22-year sale and purchase agreement with Brazil's Petrobras for about 0.

Medicus Pharma (MDCX) submitted a streamlined Phase 2b/3 FDA protocol for Teverelix in advanced prostate cancer. The proposed study would enroll about 608 patients and combine dose optimization, testosterone suppression and cardiovascular evaluation.

Biotech stocks are seeing significant pre-market activity this Tuesday driven largely by company-specific developments. Silexion Therapeutics surged on positive preclinical data, while Summit Therapeutics jumped following a $2 billion equity investment from AstraZeneca.

Johnson & Johnson reported new data on IMAAVY demonstrating sustained disease control, improved daily function and muscle strength, and reduced corticosteroid use in adolescents with generalized myasthenia gravis.

On Tuesday, Beasley Broadcast Group, Inc. (BBGI), a multi-platform media company, announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 357,000 shares of Class A Common Stock, par value $0.

Kyowa Kirin (4151.T) entered an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in Argentina, Brazil, Colombia and Mexico.

Biotechnology company Unicycive Therapeutics, Inc. (UNCY) announced Tuesday the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company's investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.

Secretary of War Pete Hegseth has signed a memorandum directing the Department of War to mobilize a comprehensive, whole-of-government defense of U.S. election infrastructure from foreign adversaries during the upcoming mid-term polls.

The North Korean representative to the United Nations told the UN General Assembly on Monday that its status as a nuclear-armed State was irreversible, arguing that its military capabilities were necessary to safeguard the country's sovereignty and maintain peace on the Korean Peninsula.

Stocks are likely to move to the upside in early trading on Tuesday, regaining ground following the weakness seen in the previous session. The major index futures are currently pointing to a modestly higher open for the markets, with the S&P 500 futures up by 0.

Canadian stocks may open with a positive bias on Tuesday as oil shed early gains and slipped into negative territory, and gold prices edged higher. According to a flash estimate, the Canadian GDP is expected to have expanded by 0.

Caterpillar Inc. (CAT) announced Tuesday an agreement to acquire John Fabick Tractor Co., a long-standing Cat dealer. The terms of the transaction were not disclosed.

NASA and Boeing provided an update on the company's Starliner spacecraft, including adding additional crew missions and certifying a new rocket for crew transportation to low Earth orbit.

SoundThinking Inc. (SSTI), a public safety technology company, on Tuesday announced that it has agreed to be acquired by Transom Capital Group. The transaction is expected to close in the fourth quarter of 2026.